Filing Overview
Registrant: Brilliant Acquisition Corporation, although the request identifies T3 Defense Inc. The filing is a Form 8-K dated September 28, 2022, filed September 29, 2022. It reports an amendment to the proposed business combination with Nukkleus Inc.
Business Context and Reporting Period
Brilliant is a special purpose acquisition company. Under the proposed transaction, Nukkleus would become the Nasdaq-listed parent company of Brilliant, with a merger subsidiary merging into Brilliant. The filing also serves as written communication under Rule 425 regarding the transaction.
Material Transaction Update
On September 28, 2022, Brilliant and Nukkleus entered into Amendment No. 2 to their merger agreement. The amendment increases the potential “Backstop Pool” of shares issuable to Brilliant public shareholders:
| Measure | Before Amendment | After Amendment |
|---|---|---|
| Maximum shares | 506,000 | 1,012,000 |
| Percentage cap | Lower of 20% of outstanding SPAC shares and rights or 506,000 | Lower of 40% of outstanding SPAC shares and rights or 1,012,000 |
The filing does not provide a clear estimate of the actual number of shares expected to be issued under the Backstop Pool.
Financial Metrics and Liquidity
This filing does not provide revenue, profit, cash flow, margins, debt, cash balance, trust-account balance, redemption figures, or other operating financial metrics. It states that completion remains subject to, among other conditions, maintaining a minimum trust-account amount after redemptions.
Outlook, Risks, and Contingencies
- The business combination may not close, may be delayed, or may not close before Brilliant’s business-combination deadline.
- Completion depends on shareholder approvals, satisfaction of transaction conditions, minimum trust-account requirements after redemptions, and certain governmental or regulatory approvals.
- The transaction could affect business relationships, operating performance, employee retention, and current business plans.
- Potential litigation, Nasdaq listing risks, securities-price volatility, regulatory changes, competitive conditions, and changes in the combined capital structure could materially affect the parties.
- The parties caution that forward-looking statements are subject to material risks and undertake no general obligation to update them.
- The filing is not an offer to sell securities or a solicitation of votes and directs investors to the Form S-4, proxy statement/prospectus, and related SEC filings.
Investor Verification Checklist
- Confirm the final terms of Amendment No. 2 and the number of shares ultimately issuable under the Backstop Pool.
- Review the Form S-4 and definitive proxy statement/prospectus for transaction conditions, valuation, dilution, redemption mechanics, and shareholder approvals.
- Verify Brilliant’s business-combination deadline and whether an extension is required or obtained.
- Review the trust-account balance, expected redemptions, and minimum trust-account requirement.
- Assess the transaction’s effect on the post-combination capital structure, Nasdaq listing, and ownership dilution.
- Review the cited annual reports, quarterly reports, and transaction risk factors for financial and legal contingencies not detailed in this 8-K.